<?xml version="1.0" encoding="UTF-8"?>
<glossary>
 <title>Abbreviations</title>
 <def-list>
  <def-item>
   <term>3TC</term>
   <def>
    <p id="Par5">Emtricitabine</p>
   </def>
  </def-item>
  <def-item>
   <term>ART</term>
   <def>
    <p id="Par6">Antiretroviral therapy</p>
   </def>
  </def-item>
  <def-item>
   <term>BIC</term>
   <def>
    <p id="Par7">Bictegravir</p>
   </def>
  </def-item>
  <def-item>
   <term>CAB</term>
   <def>
    <p id="Par8">Cabotegravir</p>
   </def>
  </def-item>
  <def-item>
   <term>CD4</term>
   <def>
    <p id="Par9">Cluster of differentiation 4</p>
   </def>
  </def-item>
  <def-item>
   <term>CINAHL</term>
   <def>
    <p id="Par10">Cumulative Index to Nursing and Allied Health Literature</p>
   </def>
  </def-item>
  <def-item>
   <term>CROI</term>
   <def>
    <p id="Par11">Conference on Retroviruses and Opportunistic Infections</p>
   </def>
  </def-item>
  <def-item>
   <term>DTG</term>
   <def>
    <p id="Par12">Dolutagravir</p>
   </def>
  </def-item>
  <def-item>
   <term>EVG</term>
   <def>
    <p id="Par13">Elvitegravir</p>
   </def>
  </def-item>
  <def-item>
   <term>FDA</term>
   <def>
    <p id="Par14">Food and drug administration</p>
   </def>
  </def-item>
  <def-item>
   <term>HIV/AIDS</term>
   <def>
    <p id="Par15">Human immunodeficiency virus infection/acquired immune deficiency syndrome</p>
   </def>
  </def-item>
  <def-item>
   <term>HIVDR</term>
   <def>
    <p id="Par16">HIV drug resistance</p>
   </def>
  </def-item>
  <def-item>
   <term>IAC</term>
   <def>
    <p id="Par17">International AIDS Conference</p>
   </def>
  </def-item>
  <def-item>
   <term>IAS</term>
   <def>
    <p id="Par18">International AIDS Society</p>
   </def>
  </def-item>
  <def-item>
   <term>ICTRP</term>
   <def>
    <p id="Par19">International Clinical Trials Registry Platform</p>
   </def>
  </def-item>
  <def-item>
   <term>INSTI</term>
   <def>
    <p id="Par20">Integrase strand transfer inhibitor</p>
   </def>
  </def-item>
  <def-item>
   <term>MeSH</term>
   <def>
    <p id="Par21">Medical Subject Headings</p>
   </def>
  </def-item>
  <def-item>
   <term>LILAC</term>
   <def>
    <p id="Par22">Latin American and Caribbean Health Sciences Literature</p>
   </def>
  </def-item>
  <def-item>
   <term>PRISMA-P</term>
   <def>
    <p id="Par23">Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols</p>
   </def>
  </def-item>
  <def-item>
   <term>RAL</term>
   <def>
    <p id="Par24">Raltegravir</p>
   </def>
  </def-item>
  <def-item>
   <term>SSA</term>
   <def>
    <p id="Par25">Sub Saharan Africa</p>
   </def>
  </def-item>
  <def-item>
   <term>TAF</term>
   <def>
    <p id="Par26">Tenofovir alafenamide</p>
   </def>
  </def-item>
  <def-item>
   <term>WHO</term>
   <def>
    <p id="Par27">World Health Organization</p>
   </def>
  </def-item>
 </def-list>
</glossary>
